Ethyl 4-bromo-6-methyl-7-oxo-1-tosyl-6,7-dihydro-1H-pyrrolo[2,3-c]pyridine-2-carboxylate, 98%, 100mg

Di-Ammonium oxalate monohydrate, min. 99.5%, pa, ACS, 100 g, plastic packaging.

TERT-BUTYL N-(3-HYDROXY-2,2-DIMETHYLCYCLOBUTYL)CARBAMATE, 95.0%, 100mg

[3-(3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]methanamine, 95.0%, 10g

1,4-Divinylbenzene (stabilized with TBC)>98.0%(GC)5g

2-(3-METHYLOXETAN-3-YL)ACETIC ACID LITHIUM SALT, 95.0%, 250mg

1,3-Di-tert-butylbenzene>98.0%(GC)1mL

2,4-Dimethoxy-5-nitropyrimidine, 95.0%, 5g

Ethyl 2-bromo-4,5,6,7-tetrahydrobenzo[d]thiazole-6-carboxylate, 97%, 1g

(3-Bromo-2,4-difluorophenyl)boronic acid, 97%, 1g

1-(6-Methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone, 95.0%, 5g

Triphenylene-2,3,6,7,10,11-hexaol hydrate, 95.0%, 250mg

2-Thiophenecarboxamide, 5-[[(5-chloro-2-methyl-3-pyridinyl)amino]methyl]-N-[(1S)-1-(cyclopentylmethyl)-2-(cyclopropylamino)-2-oxoethyl]-, 96%, 250mg